메뉴 건너뛰기




Volumn 52, Issue 1-3, 1998, Pages 125-136

Matrix metalloproteinase inhibitors

Author keywords

Collagenases; Drug design; Gelatinases; Inhibitors; Matrix metallproteinases; Metastasis; Stromelysins; TIMPs

Indexed keywords

COLLAGEN; GELATINASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN;

EID: 0032439091     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006119319695     Document Type: Review
Times cited : (91)

References (59)
  • 1
    • 0000593691 scopus 로고    scopus 로고
    • Malignant tumours of the breast
    • DeVita VT, Hellman S, Rosenberg SA (eds). Lippincott-Raven, New York
    • Harris J, Morrow M, Norton L: Malignant tumours of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principals and Practice of Oncology, 5th Edition. Lippincott-Raven, New York, 1997, pp 1557-1616
    • (1997) Cancer: Principals and Practice of Oncology, 5th Edition , pp. 1557-1616
    • Harris, J.1    Morrow, M.2    Norton, L.3
  • 4
    • 0027683226 scopus 로고
    • Structural biochemistry and activation of matrix metalloproteinases
    • Kleiner DJ, Stetler-Stevenson WG: Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 5:891-897, 1993
    • (1993) Curr Opin Cell Biol , vol.5 , pp. 891-897
    • Kleiner, D.J.1    Stetler-Stevenson, W.G.2
  • 5
    • 0030717692 scopus 로고    scopus 로고
    • Tissue inhibitors of metalloproteinases - Structure, regulation and biological functions
    • Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases - structure, regulation and biological functions. Eur J Cell Biol 74:111-122, 1997
    • (1997) Eur J Cell Biol , vol.74 , pp. 111-122
    • Gomez, D.E.1    Alonso, D.F.2    Yoshiji, H.3    Thorgeirsson, U.P.4
  • 8
    • 0027515289 scopus 로고
    • Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages
    • Shapiro SD, Kobayashi DK, Ley TJ: Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268:23824-23829, 1993
    • (1993) J Biol Chem , vol.268 , pp. 23824-23829
    • Shapiro, S.D.1    Kobayashi, D.K.2    Ley, T.J.3
  • 11
    • 0028116127 scopus 로고
    • Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3
    • Pei D, Majmudar G, Weiss SJ: Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269: 25849-25855, 1994
    • (1994) J Biol Chem , vol.269 , pp. 25849-25855
    • Pei, D.1    Majmudar, G.2    Weiss, S.J.3
  • 13
    • 0030581634 scopus 로고    scopus 로고
    • Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein
    • Chandler S, Cossins J, Lury J, Wells G: Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein. Biochem Biophys Res Conunun 228:421-429, 1996
    • (1996) Biochem Biophys Res Conunun , vol.228 , pp. 421-429
    • Chandler, S.1    Cossins, J.2    Lury, J.3    Wells, G.4
  • 14
    • 8044257704 scopus 로고    scopus 로고
    • A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
    • Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733, 1997
    • (1997) Nature , vol.385 , pp. 729-733
    • Black, R.A.1    Rauch, C.T.2    Kozlosky, C.J.3    Peschon, J.J.4    Slack, J.L.5
  • 15
    • 8044250278 scopus 로고    scopus 로고
    • Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
    • Moss ML, Jin SL, Milla ME, Burkhart W, Carter HL: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736, 1997
    • (1997) Nature , vol.385 , pp. 733-736
    • Moss, M.L.1    Jin, S.L.2    Milla, M.E.3    Burkhart, W.4    Carter, H.L.5
  • 17
    • 0029586589 scopus 로고
    • Matrix metalloproteinase inhibition: A review of anti-tumour activity
    • Brown PD, Giavazzi R: Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 6:967-974, 1995
    • (1995) Ann Oncol , vol.6 , pp. 967-974
    • Brown, P.D.1    Giavazzi, R.2
  • 18
    • 0028838862 scopus 로고
    • Structure determination and analysis of human neutrophil collagenase complexed with a hydoxamate inhibitor
    • Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W: Structure determination and analysis of human neutrophil collagenase complexed with a hydoxamate inhibitor. Biochemistry 34:14012-14020, 1995
    • (1995) Biochemistry , vol.34 , pp. 14012-14020
    • Grams, F.1    Crimmin, M.2    Hinnes, L.3    Huxley, P.4    Pieper, M.5    Tschesche, H.6    Bode, W.7
  • 19
    • 0027996297 scopus 로고
    • Potent and selective inhibitors of gelatinase A. 2 - Carboxylic acids and phosphonic acid derivatives
    • Morphy JR, Beeley NRA, Boyce BA: Potent and selective inhibitors of gelatinase A. 2. Carboxylic acids and phosphonic acid derivatives. Bioorg Med Chem Lett 4:2747-2752, 1994
    • (1994) Bioorg Med Chem Lett , vol.4 , pp. 2747-2752
    • Morphy, J.R.1    Beeley, N.R.A.2    Boyce, B.A.3
  • 20
    • 0030816454 scopus 로고    scopus 로고
    • Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases
    • Santos O, McDermott CD, Daniels RG, Appelt K: Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases. Clin Exp Met 15: 499-508, 1997
    • (1997) Clin Exp Met , vol.15 , pp. 499-508
    • Santos, O.1    McDermott, C.D.2    Daniels, R.G.3    Appelt, K.4
  • 23
    • 0002338012 scopus 로고    scopus 로고
    • The tolerability and pharmacokinetics of the cartilage protective agent (Ro32-3555) in healthy male volunteers
    • Wood ND, Aitken M, Harris S, Kitchener S, McClelland GR, Sharp S: The tolerability and pharmacokinetics of the cartilage protective agent (Ro32-3555) in healthy male volunteers. Br J Clin Pharm 42:676-677, 1996
    • (1996) Br J Clin Pharm , vol.42 , pp. 676-677
    • Wood, N.D.1    Aitken, M.2    Harris, S.3    Kitchener, S.4    McClelland, G.R.5    Sharp, S.6
  • 24
    • 0030475119 scopus 로고    scopus 로고
    • Recent advances in the field of matrix metalloproteinase inhibitors (patent update)
    • Beckett RP: Recent advances in the field of matrix metalloproteinase inhibitors (patent update). Exp Opin Ther Patents 6:1305-1315, 1996
    • (1996) Exp Opin Ther Patents , vol.6 , pp. 1305-1315
    • Beckett, R.P.1
  • 25
    • 0030949716 scopus 로고    scopus 로고
    • Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733
    • Lee H-J, Chung M-C, Lee C-H, Yun B-S, Chun H-K, Kho Y-H: Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733. J Antibiot 50:357-359, 1996
    • (1996) J Antibiot , vol.50 , pp. 357-359
    • Lee, H.-J.1    Chung, M.-C.2    Lee, C.-H.3    Yun, B.-S.4    Chun, H.-K.5    Kho, Y.-H.6
  • 26
    • 0027519832 scopus 로고
    • Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]
    • Naito K, Nakajima S, Kanbayashi N, Okuyama A, Goto M: Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]. Agents Actions 39:182-186, 1993
    • (1993) Agents Actions , vol.39 , pp. 182-186
    • Naito, K.1    Nakajima, S.2    Kanbayashi, N.3    Okuyama, A.4    Goto, M.5
  • 27
    • 0023245356 scopus 로고
    • A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity
    • Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS: A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dental Res 66:1310-1314, 1987
    • (1987) J Dental Res , vol.66 , pp. 1310-1314
    • Golub, L.M.1    McNamara, T.F.2    D'Angelo, G.3    Greenwald, R.A.4    Ramamurthy, N.S.5
  • 28
    • 0023919232 scopus 로고
    • Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells
    • Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307-3312, 1988
    • (1988) Cancer Res , vol.48 , pp. 3307-3312
    • Reich, R.1    Thompson, E.W.2    Iwamoto, Y.3    Martin, G.R.4    Deason, J.R.5    Fuller, G.C.6    Miskin, R.7
  • 29
    • 0028129059 scopus 로고
    • Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
    • Chirivi RS, Garofalo A, Crimmin MJ, Bawden LJ, Brown PD, Giavazzi RG: Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58:460-464, 1994
    • (1994) Int J Cancer , vol.58 , pp. 460-464
    • Chirivi, R.S.1    Garofalo, A.2    Crimmin, M.J.3    Bawden, L.J.4    Brown, P.D.5    Giavazzi, R.G.6
  • 30
    • 0027994031 scopus 로고
    • Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice
    • Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM: Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54:4726-4728, 1994
    • (1994) Cancer Res , vol.54 , pp. 4726-4728
    • Wang, X.1    Fu, X.2    Brown, P.D.3    Crimmin, M.J.4    Hoffman, R.M.5
  • 32
    • 0025351278 scopus 로고
    • Identification of an inhibitor of neovascularization from cartilage
    • Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248:1408-1410, 1990
    • (1990) Science , vol.248 , pp. 1408-1410
    • Moses, M.A.1    Sudhalter, J.2    Langer, R.3
  • 34
    • 0029934985 scopus 로고    scopus 로고
    • Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
    • Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD: Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 56:2815-2822, 1996
    • (1996) Cancer Res , vol.56 , pp. 2815-2822
    • Eccles, S.A.1    Box, G.M.2    Court, W.J.3    Bone, E.A.4    Thomas, W.5    Brown, P.D.6
  • 35
    • 0028889359 scopus 로고
    • Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice
    • Sledge GW, Qulali M, Goulet R, Bone EA, Fife R: Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Res 87: 1546-1550, 1995
    • (1995) J Natl Cancer Res , vol.87 , pp. 1546-1550
    • Sledge, G.W.1    Qulali, M.2    Goulet, R.3    Bone, E.A.4    Fife, R.5
  • 39
    • 0026085334 scopus 로고
    • Double-blind, placebo-controlled study of the three month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
    • Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H: Double-blind, placebo-controlled study of the three month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 24:6-14, 1991
    • (1991) Arthritis Rheum , vol.24 , pp. 6-14
    • Lauhio, A.1    Leirisalo-Repo, M.2    Lahdevirta, J.3    Saikku, P.4    Repo, H.5
  • 40
    • 0028631107 scopus 로고
    • Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis
    • Greenwald RA, Moak SA, Golub LM: Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis. Ann NY Acad Sci 732:419-421, 1994
    • (1994) Ann NY Acad Sci , vol.732 , pp. 419-421
    • Greenwald, R.A.1    Moak, S.A.2    Golub, L.M.3
  • 42
    • 0019835719 scopus 로고
    • CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer
    • Goldenberg DM, Neville A, Carter A: CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer. J Cancer Res Clin Oncol 101:239-242, 1981
    • (1981) J Cancer Res Clin Oncol , vol.101 , pp. 239-242
    • Goldenberg, D.M.1    Neville, A.2    Carter, A.3
  • 43
    • 0022625713 scopus 로고
    • Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas
    • Steinberg W, Gelfand R, Anderson K: Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas. Gastroenterology 90:343-349, 1986
    • (1986) Gastroenterology , vol.90 , pp. 343-349
    • Steinberg, W.1    Gelfand, R.2    Anderson, K.3
  • 44
    • 0024518775 scopus 로고
    • CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
    • Rubin SC, Hoskins WJ, Hakes TB: CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 160:667-671, 1989
    • (1989) Am J Obstet Gynecol , vol.160 , pp. 667-671
    • Rubin, S.C.1    Hoskins, W.J.2    Hakes, T.B.3
  • 45
    • 0024599612 scopus 로고
    • Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
    • Starney TA, Kabalin JW, McNeal JE: Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141:1076-1083, 1989
    • (1989) J Urol , vol.141 , pp. 1076-1083
    • Starney, T.A.1    Kabalin, J.W.2    McNeal, J.E.3
  • 46
    • 0000003860 scopus 로고    scopus 로고
    • 360 Patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor
    • Millar A, Brown P: 360 patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor. Ann Oncol 7:123, 1996
    • (1996) Ann Oncol , vol.7 , pp. 123
    • Millar, A.1    Brown, P.2
  • 47
    • 0002750508 scopus 로고    scopus 로고
    • A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer
    • Poole C, Adams M, Barley V, Graham J, Kerr D, Louviaux I, Perren T, Piccart M, Thomas H: A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer. Ann Oncol 7:68, 1996
    • (1996) Ann Oncol , vol.7 , pp. 68
    • Poole, C.1    Adams, M.2    Barley, V.3    Graham, J.4    Kerr, D.5    Louviaux, I.6    Perren, T.7    Piccart, M.8    Thomas, H.9
  • 48
  • 49
    • 0002635973 scopus 로고    scopus 로고
    • An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer
    • Parsons SL, Watson SA, Griffin NR, Steele RJC: An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer. Ann Oncol 7:47, 1996
    • (1996) Ann Oncol , vol.7 , pp. 47
    • Parsons, S.L.1    Watson, S.A.2    Griffin, N.R.3    Steele, R.J.C.4
  • 50
    • 0343900695 scopus 로고    scopus 로고
    • A phase I clinical trial of the MMP inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer
    • Thomas H, Adams M: A phase I clinical trial of the MMP inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer. Eur J Cancer 33:S246, 1997
    • (1997) Eur J Cancer , vol.33
    • Thomas, H.1    Adams, M.2
  • 51
    • 0030042145 scopus 로고    scopus 로고
    • Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma
    • Anderson IC, Shipp MA, Docherty AJP, Teicher BA: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56:715-718, 1996
    • (1996) Cancer Res , vol.56 , pp. 715-718
    • Anderson, I.C.1    Shipp, M.A.2    Docherty, A.J.P.3    Teicher, B.A.4
  • 54
    • 0015187844 scopus 로고
    • The relative significance of prognostic factors in breast carcinoma
    • Alderson MR, Hamlin I, Staunton MD: The relative significance of prognostic factors in breast carcinoma. Br J Cancer 25:646-656, 1971
    • (1971) Br J Cancer , vol.25 , pp. 646-656
    • Alderson, M.R.1    Hamlin, I.2    Staunton, M.D.3
  • 56
    • 0016378540 scopus 로고
    • Fibrosis as an indication of time in infiltrating breast cancer and its importance in prognosis
    • Anastassiades OT, Pryce PM: Fibrosis as an indication of time in infiltrating breast cancer and its importance in prognosis. Br J Cancer 29:232-239, 1974
    • (1974) Br J Cancer , vol.29 , pp. 232-239
    • Anastassiades, O.T.1    Pryce, P.M.2
  • 57
    • 0026648071 scopus 로고
    • Simplified method of grading primary carcinomas of the breast
    • Parham DM, Hagen N, Brown RA: Simplified method of grading primary carcinomas of the breast. J Clin Pathol 45:517-520, 1992
    • (1992) J Clin Pathol , vol.45 , pp. 517-520
    • Parham, D.M.1    Hagen, N.2    Brown, R.A.3
  • 59
    • 0028959485 scopus 로고
    • Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma
    • Takei H, Iino Y, Horiguchi J, Yakoe T: Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma. Oncology 52:106-111, 1995
    • (1995) Oncology , vol.52 , pp. 106-111
    • Takei, H.1    Iino, Y.2    Horiguchi, J.3    Yakoe, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.